SCHEMBL7129830

SCHEMBL7129830

Nc1nc(-c2cccc(NC(=O)c3cc([N+](=O)[O-])ccc3Cl)c2)cs1

nearest known ligand 0.59

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PPARG P37231 6/20 0.59
RORC P51449 5/20 0.59
SMN1; SMN2 Q16637 5/20 0.59
MEN1 O00255 4/20 0.59
KMT2A Q03164 4/20 0.59
MAPT P10636 4/20 0.59
MAPK1 P28482 3/20 0.59
CYP3A4 P08684 2/20 0.59
LMNA P02545 1/20 0.59
TP53 P04637 1/20 0.59
CYP1A2 P05177 1/20 0.59
CYP2D6 P10635 1/20 0.59
CYP2C9 P11712 1/20 0.59
PKM P14618 1/20 0.59
TSHR P16473 1/20 0.59
NFKB1 P19838 1/20 0.59
CYP2C19 P33261 1/20 0.59
THPO P40225 1/20 0.59
MTOR P42345 1/20 0.59
PMP22 Q01453 1/20 0.59

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7127823 0.89 PPARG (0.60) PPARGRORCSMN1; SMN2MEN1KMT2A
SCHEMBL7123649 0.88 MEN1 (0.62) PPARGRORCSMN1; SMN2MEN1KMT2A
SCHEMBL7128853 0.86 MAPT (0.62) PPARGRORCSMN1; SMN2MEN1KMT2A
SCHEMBL7125926 0.83 MEN1 (0.64) RORCSMN1; SMN2MEN1KMT2AMAPT
SCHEMBL7130345 0.83 MEN1 (0.73) SMN1; SMN2MEN1KMT2AMAPTCYP3A4
SCHEMBL7128352 0.81 RORC (0.81) PPARGRORCSMN1; SMN2MEN1KMT2A
SCHEMBL7128172 0.81 MEN1 (0.58) PPARGRORCSMN1; SMN2MEN1KMT2A
SCHEMBL7129226 0.81 MEN1 (0.56) PPARGRORCSMN1; SMN2MEN1KMT2A
SCHEMBL7128794 0.80 MEN1 (0.69) PPARGRORCSMN1; SMN2MEN1KMT2A
SCHEMBL7122824 0.80 PPARG (0.58) PPARGRORCSMN1; SMN2MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-1440383-A PPAR gamma modulators SANKYO CO (JP) 2003-09-03 CN disclosed
US-20030134859-A1 PPAR-gamma modulator SANKYO COMPANY, LIMITED (JP) 2003-07-17 US disclosed
EP-1277729-A1 PPAR (GAMMA) MODULATORS Sankyo Company, Limited (JP) 2003-01-22 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20030134859-A1 PPAR-gamma modulator PPARG, PPARA, PPARD PPARG 1/4885RORC 67/4885SMN1; SMN2 3743/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.